TrialClinical pharmacology in drug development2022

P-Glycoprotein and Breast Cancer Resistance Protein Transporter Inhibition by Cyclosporine and Quinidine on the Pharmacokinetics of Oral Rimegepant in Healthy Subjects.

Rajinder Bhardwaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.